Revelation Biosciences Inc (REVB) — Defensive Interval Ratio
Revelation Biosciences Inc (REVB) has a Defensive Interval Ratio of 1238339 days as of December 2024. Defensive assets of $6.49 Billion (cash $-, short-term investments $6.49 Billion, receivables $-) cover 1238339 days of daily cash needs of $5.24K/day. See Revelation Biosciences Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Revelation Biosciences Inc Defensive Interval Ratio (2017–2024)
This chart shows how Revelation Biosciences Inc's Defensive Interval Ratio has evolved across 5 annual periods from 2017 to 2024. As of December 2024, the ratio stands at 1238339 days, meaning defensive assets of $6.49 Billion can fund 1238339 days of operations without new revenue. See REVB net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Revelation Biosciences Inc (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for Revelation Biosciences Inc from 2017 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Revelation Biosciences Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 1238339 days | $6.49 Billion | $5.24K/day | $- | $6.49 Billion | ▲ +1238284 days |
| 2020 | 56 days | $525.29K | $9.41K/day | $- | $525.29K | ▼ -2682026 days |
| 2019 | 2682082 days | $193.32 Million | $72.08/day | $- | $185.66 Million | ▲ +2682049 days |
| 2018 | 33 days | $194.41 Million | $5.81 Million/day | $- | $187.56 Million | ▼ -1 days |
| 2017 | 34 days | $169.09 Million | $4.92 Million/day | $- | $163.23 Million | — |